aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
aTyr Pharma (LIFE) Misses Q4 EPS by 3c
March 14, 2022 4:00 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More